Smart cap Easylog receives CE mark approval

3rd January 2018

BIOCORP

Enaie Azambuja

0 0

BIOCORP has announced that is has received CE marking for its smart cap Easylog. "CE marking for Easylog is a significant step for BIOCORP. Our ambition is to develop and market innovative devices boosting compliance, a key factor for the successful treatment of chronic conditions such as diabetes. Easylog device, which generates interest of many industrial players internationally, brings an extra dimension to the customisation of treatments".

"We are particularly pleased to reach this milestone that confirms our pioneering position in the digitalisation of drug delivery devices and will contribute to achieve our growth objectives", commented Eric Dessertenne, Chief Operating Officer of BIOCORP.

Easylog is a smart sensor that turns all classic pen injectors, disposable and reusable, into connected devices. Easylog captures key treatment information (dose, date, time) and transfers it to a monitoring mobile app. This innovative solution goes hand in hand with a dedicated application that aims to facilitate the life of patients monitoring their treatment.

CE marking has been received for a version compatible with insulin delivery devices. Market launch is planned for 2018 through partnerships. These partnerships may be subject to further communication.